Evaluation of the mutagenic activity of hydroxyurea on the G1-S-G2 phases of the cell cycle: an in vitro study.
D000704:Analysis of Variance; D000970:Antineoplastic Agents / Q000633:toxicity*; D002869:Chromosome Aberrations / Q000139:chemically induced*; D023381:Endpoint Determination; D016193:G1 Phase / Q000187:drug effects / Q000235:genetics; D016195:G2 Phase / Q000187:drug effects / Q000235:genetics; D006801:Humans; D006918:Hydroxyurea / Q000633:toxicity*; D007399:Interphase / Q000187:drug effects* / Q000235:genetics; D008214:Lymphocytes / Q000187:drug effects*; D008940:Mitotic Index; D009152:Mutagenicity Tests / Q000379:methods; D016196:S Phase / Q000187:drug effects / Q000235:genetics
D000970:Antineoplastic Agents; D006918:Hydroxyurea